GOSSAMER BIO INC
GOSS · NASDAQ
更新於 2026-10-14 09:20:46
$9.76+5.17%
- 今日最高
- $10.03
- 今日最低
- $9.26
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $9.54
- 昨天收盤價
- $9.28
- 成交量
- 155.2K
- 市值
- $56.7M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.56
昨天價格區間
$8.99$9.54
52週價格區間
$9.10$309.60
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 3115 MERRYFIELD ROW, SAN DIEGO, CA, UNITED STATES, 92121
- 國家
- 美國
- 上市日期
- 2019-02-08
- 財年截止
- 十二月
- 流通股數
- 488.85M
- CIK
- 0001728117
Gossamer Bio, Inc. 是一家臨床階段生物製藥公司，專注於在美國發現、收購、開發及商業化免疫學、炎症及腫瘤疾病領域的療法。該公司總部位於加州聖地亞哥。
財務指標
營業收入
2026-06-30
$9.23M
2026-03-31
$16.95M
2025-12-31
$13.79M
2025-09-30
$13.29M
營業支出
2026-06-30
$35.31M
2026-03-31
$61.58M
2025-12-31
$59.83M
2025-09-30
$62.4M
淨利潤
2026-06-30
$16.9M
2026-03-31
-$46.66M
2025-12-31
-$47.23M
2025-09-30
-$48.22M
淨利潤率
2026-06-30
182.94%
2026-03-31
-275.22%
2025-12-31
-342.32%
2025-09-30
-362.72%
每股收益
2026-06-30
$-0.20
2026-03-31
$-0.20
2025-12-31
$-0.21
2025-09-30
$-0.21
息稅折舊攤銷前利潤
2026-06-30
-$71.23M
2026-03-31
-$43.67M
2025-12-31
-$44.34M
2025-09-30
-$45.25M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
0.18%
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $9.23M | $16.95M | $13.79M | $13.29M |
| 營業支出 | $35.31M | $61.58M | $59.83M | $62.4M |
| 淨利潤 | $16.9M | -$46.66M | -$47.23M | -$48.22M |
| 淨利潤率 | 182.94% | -275.22% | -342.32% | -362.72% |
| 每股收益 | $-0.20 | $-0.20 | $-0.21 | $-0.21 |
| 息稅折舊攤銷前利潤 | -$71.23M | -$43.67M | -$44.34M | -$45.25M |
| 有效稅率 | -- | -- | 0.18% | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。